The Senate will vote Thursday on whether to put RFK Jr. in charge of health. It's unclear how he will impact biotech stocks.
Co (market cap: $42.4 billion) reported robust Q4 2024 earnings, exceeding Wall Street forecasts with adjusted earnings per share (EPS) of $0.99, compared to the expected $0.82. Revenue also surpassed ...